Loading...
Trastuzumab emtansine: the first targeted chemotherapy for treatment of breast cancer
Trastuzumab emtansine (T-DM1) is a novel antibody–drug conjugate, comprised of a potent cytotoxic drug connected via a stable linker to the anti-HER2 antibody, trastuzumab, thereby primarily targeting chemotherapy delivery to cells overexpressing the HER2 receptor. A Phase II randomized trial of T-D...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3860880/ https://ncbi.nlm.nih.gov/pubmed/23469968 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fon.13.7 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|